X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-Apparently-To: jeeproject@yahoo.com via 72.30.238.181; Wed, 08 Jan 2014 07:57:28 -0800
Return-Path: <info@updates.f1000.com>
Received-SPF: pass (domain of updates.f1000.com designates 81.92.113.150 as permitted sender)
X-YMailISG: g6nFMZQWLDtAyiAJBGW7SzJT3HJ6YtYhflocJaadzwVRDWso
 wDUMePqigUrAiTFW_zdEunIQGouwvNh8FEtiOylWRU3jRpzCs0YmcI1Rxmae
 YobKTzDIn5sTu6J7Hf56mIbfsCW_vYmxELiOHl4HjbYy7K1wdfSWH92naaUM
 mGu1YXC5W2PeQfG3IxY8l3nFuwx4KBaAP.esPZ7ttPPg54v3BLsfpoMny.qK
 faGXhssMc_FGsVueqWxyqpyU5Yd4l8x0zoxug88oQUwnoNAqINtIZCu71koD
 0Cj1mwd6QL3YdpT2_490Pt.2zvUdoO2nYvVfv06juYqiMDOB.vKUcn9ObDs4
 _xHkOZgmPGP3du5POStXKUXBu3QByPne82HFBlB9BcSg8WnMkZGamCJUM2ul
 fDPCLMoeDLuYTDsh188UR.l8gLa1oH19HnibnpzbxgNDNP.kT0ihed02b7Qn
 9zZ969FGwwtr_2KgVOKGsRtWZ6yatxSJh4G7Pxmil0qJIwaZUO63yCeCEimG
 8ObxUtWjcgLVpigccSy0twBm33HOrjIC82jsLTVw1fshYL1BNBJjeFFFgyZH
 9vl4GWHX3mWLLNIAelE6D0a0h.GjAtx1uTomA6gldL0hLx_DADOhwjefRdMQ
 aK5c5Wbe2k_WZbmQ1jr9G6ruq9_Q4Grfv1hOxsnqLOu_HpRYKLNRHue1UkQM
 eUzIUJbDmoMZOosfteJw3VBhv0oeOaMr8Iwol2G1z_hQBtjUm09jxvCi.jCk
 ydSi1fDMVPUTmea.Zxf0ykkH0neshGcd7XQx3nleKrvIoHjVYgpAZD8JeNIk
 rY_PrqExQUtAZpjW49jo6YySIsj3NEi0eG8BAbWdk6scXFv.wWJIGqQu0a0b
 ND56W00TdCVF8c..68UlMPPYO5Oi1Ms1ddDph75TqT37NiCaYo7hY0o_ojHe
 V9B.snNeeTrv3J8u7XsCei7m96KX_CIDL8EpZaS.JiQ15Mym5AcwZ14wDqwJ
 Zny2uUzc_7Nkv1oLvxq7LWCMcS3nJVjs11KgcRbdSrGkYrSXS0MGeDIIZCu8
 Y_.l2ZhdDxP4RhdphUXEZvhiDRUYsvs4QMHER6jFUC.ubEKGnfU7krXZj75E
 et.uFulsCASAp2kcMDXOGDAluskjBjBoZV1kfykSwPDHxleGMzTwH2PnTwvd
 _LjTGDnrleAf0NKsytuDRS4rK8C9D3lfsK.s_i_YLai1Ha9mFiJ9yn2TzvfJ
 _kbaARLsrZGcAhKHbqMD1xXe8QDRu59tdJ.zOZu.uNLbfqO.gYuz40IEHBqc
 FMtbE1E5dlUAI.9.q74PB0QD_uaydzrsFiafDcoUPUTNQjDr1IUZibRJ8yEu
 xtp2VFVKE0oHIzg1LrreVTnpPEKIjdTlLNfObL0BiU3G1Fi66Mw_qzfHr_Md
 OCqY6tmdy87M13fjbNgV.aNwOHTP99B_N7uPVo_8i2xlaKIajeZ.LTrWH5h8
 hQuiGqZnsbPNIosy69r27xFsITS_DAh9pfZxnGoPPgUXqUcNNHU9yKm6DGAI
 Nap63.OjQCZ0jQ8u9ks9z5lyrqC7OyKJEXnX3ryn.FswusYzypXdaTb5dyG5
 DjfycFie2f8QTIrDuXsxKEF5Sfcni1i0sVdXOzdDloAy8BEAoommqkZwVj17
 rY0B8SUrlCDIh4_0JNJxIJdd_RaEAuy.tnllEfp2hi1nyaYm3QtRl8w0MmSJ
 yaLM7mvXW3OBy.sC5C6miO5t2QmdJmw1MEnhdH1onzi_ovhIYRM4uxcLDTXl
 jdhiM7eXfzeunhb7xaQ3R9WengnamKN5Dc1htuZQS7PisGXG8_MLzRuH4E2i
 EbGtQbMwmNj.7hwMxg--
X-Originating-IP: [81.92.113.150]
Authentication-Results: mta1264.mail.bf1.yahoo.com  from=updates.f1000.com; domainkeys=neutral (no sig);  from=updates.f1000.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO emailer113-150.emv5.com) (81.92.113.150)
  by mta1264.mail.bf1.yahoo.com with SMTP; Wed, 08 Jan 2014 07:57:27 -0800
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=emv; d=updates.f1000.com;
 h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type:List-Unsubscribe; i=info@updates.f1000.com;
 bh=BrRxzxWyHbvtB6pCo/d7A3uq3Nw=;
 b=T+Kg6CcwAM8Oz6eRJRC97dr1JWEG1CZ6fMOppaL03RFTRb88YN0ZMZR2cmnjqcujxVSsQLz7kJeI
   TBvNAoenAZ7FRyv6vX0p8LwXd8hNglTjTfOIbN4tGv+bb+omMlGul7rcE8zIyU9zzhdhSv2MA9J7
   JR9xrKRcBnTogCtC/j8=
Received: by emailer113-150.emv5.com id hplqme16758i for <jeeproject@yahoo.com>; Wed, 8 Jan 2014 16:51:16 +0100 (envelope-from <info@updates.f1000.com>)
Return-Path: info@updates.f1000.com
Date: Wed, 8 Jan 2014 16:51:16 +0100 (CET)
From: Faculty of 1000 <info@updates.f1000.com>
Reply-To: Faculty of 1000 <info@f1000.com>
To:  <jeeproject@yahoo.com>
Message-ID: <2.1.4.1101019921.2466696.807521937@updates.f1000.com>
Subject: F1000Research in PubMed; Happy new year from F1000!
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary=2466696807521937
X-EMV-Platform: p4ccc.campaigncommander.com$
X-EMV-CampagneId: 2466696$
X-EMV-MemberId: 807521937$
List-Unsubscribe: <http://p4trc.emv2.com/HD?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjI0a_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLK>, <mailto:unsubscribe@updates.f1000.com?subject=unsubscribe-4-ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjI0a_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLK>
Content-Length: 66182

--2466696807521937
Content-Type: text/plain; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

To ensure you receive emails from Faculty of 1000, add info@updates.f1000.com to your safelist.

-----------------------------------------------------

Faculty of 1000 |  http://f1000.com                
Monthly Update  |  January 2014 

-----------------------------------------------------

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 F1000Research peer-reviewed articles now visible on PubMed and PubMed Central     
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 

The first set of articles to have been published and passed peer-review in F1000Research [ http://f1000research.com/ ] is now visible in PubMed [ http://www.ncbi.nlm.nih.gov/pubmed ] and PubMed Central (PMC) [ http://www.ncbi.nlm.nih.gov/pmc/ ]. From now on, all our articles will be deposited here as soon as they pass peer review.

We have worked closely with the National Library of Medicine (NLM) [ http://www.nlm.nih.gov/ ] to ensure the additional article information captured via our unique publishing model (corresponding referee reports, author responses and underlying data) is accessible in PMC. The inclusion of the referee reports in PMC should help to provide referees with increased visibility and credit for the time taken in providing referee reports.

Find out more in our blog post [ http://blog.f1000research.com/2013/12/12/f1000research-now-visible-on-pubmed-and-pubmed-central/ ]. 

 

   F1000Prime                             
==================

1,340 recommendations  [ http://f1000.com/prime/search/evaluations ] added in the past month. Below is a selection:  

Brain detox      
[ http://f1000.com/prime/718147564?key=Sip2fvynKevd67N ]   
Evidence from a mouse study that sleep flushes out injurious metabolites from the adult brain by enhancing the flow of interstitial fluid.      
Xie L, Kang H, Xu Q et al.   
Science. 2013; 342:373-7   

What does pain look like?    
[ http://f1000.com/prime/717999439?key=PYW1qGfPiN1Sshd ]   
Pain is subjective, but a controversial article suggests that an objective neural signature for pain may exist in brain activation patterns viewed via fMRI.    
Wager TD, Atlas LY, Lindquist MA et al.   
N Engl J Med. 2013; 368:1388-97

No salt please    
[ http://f1000.com/prime/718133765?key=EaJd5wWC1mwiy6S ]    
These very simple experiments in plants show a new type of tropism -- halotropism -- whereby plant roots avoid salty environments.    
Galvan-Ampudia CS, Julkowska MM, Darwish E et al.   
Curr Biol. 2013; 23:2044-50   

* F1000Prime Reports *  

Open-access review journal [ http://f1000.com/prime/reports/ ], reporting on the hottest topics.

Advances in treating psoriasis    
[ http://f1000.com/prime/reports/m/6/04 ]    
New and better therapies for psoriasis and psoriatic arthritis are headed for the clinic.    
F1000Prime Report by Belge K, Brück K, Ghoreschi K [ http://f1000.com/prime/thefaculty/member/9641802225493883 ].   
F1000Prime Rep 2014, 6:4   

 ---------------
 See all recent F1000Prime Reports          
 >> http://f1000.com/prime/reports/                 
 ---------------   
    


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 F1000 Specialist programme     
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
If you would like to get better connected with Faculty of 1000, please join our network of F1000 Specialists. More details here [ http://f1000.com/specialists ].

 ---------------
 Apply now
 >> http://f1000.com/specialists 
 ---------------
 


   F1000Research                      
======================

Our innovative open access journal [ http://f1000research.com/ ] offering rapid publication, open peer review and open data.

Below is a selection of our latest peer reviewed articles:  


OPINION ARTICLE
Are we divorced from the species we study? [ http://f1000research.com/articles/2-254/v1 ] [v1; ref status: indexed, http://f1000r.es/2cr ]   
Latest Published: 22 Nov 2013   
Smith DR.   
F1000Research 2:254   

SHORT RESEARCH ARTICLE
Cladonia lichens on extensive green roofs: evapotranspiration, substrate temperature, and albedo [ http://f1000research.com/articles/2-274/v1 ] [v1; ref status: indexed, http://f1000r.es/2ha ]   
Published: 16 Dec 2013   
Heim A, Lundholm J.   
F1000Research 2:274   

SHORT RESEARCH ARTICLE
A novel role for syndecan-3 in angiogenesis [ http://f1000research.com/articles/2-270/v1 ] [v1; ref status: indexed, http://f1000r.es/2g6 ]   
Published: 09 Dec 2013   
De Rossi G, Whiteford JR.   
F1000Research 2:270   

RESEARCH ARTICLE
A computational analysis of the long-term regulation of arterial pressure [ http://f1000research.com/articles/2-208/v2 ] [v2; ref status: indexed, http://f1000r.es/2hm ]   
Latest Published: 06 Dec 2013
Beard DA, Pettersen KH, Carlson BE et al.   
F1000Research 2:208


 ---------------------------------------------
  Submit now to F1000Research          
  >> http://f1000research.com/author/submit        
 ----------------------------------------------


   F1000Trials                     
==================

A comprehensive listing [ http://f1000.com/trials ] of clinical trial articles reviewed by the F1000 Faculty, with the most important tagged as recommended.

Below is a taster of F1000Trials content. To read, please sign-in [ http://f1000.com/trials/signin ] or register for free [ http://f1000.com/trials/register ]:  

Hope for HCV    
[ http://f1000.com/trials/718170953?key=ivz2Er0iPp8v7x3 ]   
HCV-associated end-stage liver disease will reach its peak over the next 10 years, but new treatment options for difficult-to-treat patients are on the horizon.   
Lawitz E, Poordad FF, Pang PS et al.    
Lancet. 2013; S0140-6736(13)62121-2

What's in a name?    
[ http://f1000.com/trials/718192275?key=9unniNWUsZPSN25 ]  
An RCT looks at the language used to describe palliative services for advanced cancer patients and whether it affects their views.   
Maciasz RM, Arnold RM, Chu E et al.   
Support Care Cancer. 2013; 21:3411-9   

Competing comorbidities 
[ http://f1000.com/trials/718123161?key=nYEmtL0suGUCxlI ]    
This work on whether comorbid anxiety disorders moderate the effects of bipolar disorder psychotherapy "shows the importance of treating comorbidities adequately".    
Deckersbach T, Peters AT, Sylvia L et al.      
Am J Psychiatry. 2013; [Epub ahead of print]       

    
    F1000Posters                 
======================
 
Open Repository [ http://f1000.com/posters ] for posters and slide presentations; completely free to view and submit. Below are a few selections:

* ECOLOGY *

Calcareous sponges are fashion    
[ http://f1000.com/posters/browse/summary/1094681 ]
Padua A, Fonseca CA, Silva-Ferreira TCG et al.   
F1000Posters 2013, 4:1377   

* COMPUTATIONAL BIOLOGY *

Biomedical text mining for disease-gene discovery    
[ http://f1000.com/posters/browse/summary/1094863 ]
ElShal S, Davis J, Moreau Y.
F1000Posters 2013, 4:1516

* ANESTHESIOLOGY & PAIN MANAGEMENT *

Pharmacokinetic modeling for optimization of opioid dosing regimens    
[ http://f1000.com/posters/browse/summary/1094570 ]
Linares O, Daly D, Stefanovski D et al.   
F1000Posters 2013, 4:1298

 ----------------------------------------------
  Deposit now        
  >> http://f1000.com/posters/fordepositors      
 ---------------------------------------------- 
 
  
----------------------

 * F1000Tips *

Follow @F1000Tips on Twitter [ http://twitter.com/f1000tips ] for tips, tricks, and customer support for all Faculty of 1000 service.

---------------------- 

-----------------------------------------------------   

In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).

You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may unsubscribe [ http://www.f1000.com/unsubscribe/email?email=jeeproject@yahoo.com&emailAlertType=MONTHLY_UPDATES ] at any time. For further information or enquiries please contact Customer Services at info@f1000.com [ mailto:info@f1000.com ].

Faculty of 1000 Ltd | Science Navigation Group
Registered in England and Wales with Company Number 3739756
Middlesex House, 34-42 Cleveland Street | London, W1T 4LB | United Kingdom

--2466696807521937
Content-Type: text/html; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

<html><!--"Multipart/Alternative MIME" format-->
<style type="text/css">
	.footer a, .footer a:visited { color:#CCCCCC;}
	blockquote .hide-forwarded {display: none !important;}
</style>
	<body leftmargin="0" marginwidth="0" topmargin="0" marginheight="0" offset="0">
		<table width="100%" border="0" cellpadding="0" cellspacing="0">
			<tr>
				<td>
					<table width="640" align="center" border="0" cellpadding="0" cellspacing="0" >
						<!-- BEGIN Header -->
							<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td colspan="5" style="text-align:center;color:#666;font-family:arial,sans-serif;font-size:11px;">
								<strong style="font-weight:bold;">To ensure you receive F1000 emails, add <a style="color:#CB2D2D; text-decoration: none;" href="mailto:info@updates.f1000.com">info@updates.f1000.com</a> to your safelist.<br>If this email is not displaying properly, please <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HM?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJIfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLH">view in your usual browser</a>.</strong>							</td>
					  </tr>
						<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJefcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKP"><img src="http://p4trr.emv2.com/IL/9/2/1/1101019921/217086484.jpg" style="display:block;"width="468" height="60" border="0" alt="" title="Top Banner"/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
						</tr>

						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
							<td colspan="3">
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<!-- BEGIN Network Bar -->
									<tr>
										<td colspan="3" width="100%">
											<table style="background-color: #222222;" border="0" cellpadding="0" cellspacing="0" width="640">
												<tr>
													<td width="10" height="30">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="10" height="1" style="display:block;">
													</td>
													<td width="80">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJfvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKM" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000prime.gif" width="80" height="30" border="0" title="Network Bar - Prime">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="76">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJf_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKN" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000trials.gif" width="76" height="30" border="0" title="Network Bar - Trials">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="102">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJfPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKS" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000research.gif" width="102" height="30" border="0" title="Network Bar - Research">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="91">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJffcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKT" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000posters.gif" width="91" height="30" border="0" title="Network Bar - Posters">
														</a>
													</td>
													<td width="176">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
												</tr>
											</table>
										</td>
									</tr>
									<!-- END Network Bar -->
									<!-- BEGIN Header Image -->
									<tr>
										<td colspan="3" width="640" height="70">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJcvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKQ"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/monthly_update_email_header_grey.gif" border="0" width="640" height="70" title="F1000 Monthly Update Email Header" alt="F1000 Monthly Update Email Header" style="display:block;"/></a>
										</td>
									</tr>
									<!-- END Header Image -->
								</table>
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Header -->
						<!-- BEGIN Content -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Left Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="478">
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="15"></td>
									</tr>
									<!-- BEGIN Date and Intro -->
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:18px;">
											January 2014
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;"><em>F1000Research</em> peer-reviewed articles now visible on PubMed and PubMed Central</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:normal; color:#383838;font-family:'arial bold',sans-serif;font-size:12px;">The  first set of articles to have been published and passed peer-review in <a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJc_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKR"><em>F1000Research</em></a> is now visible in <a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJcPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKW">PubMed</a> and <a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJcfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKX">PubMed Central (PMC)</a>. From now on,  all our articles will be deposited here as soon as they pass peer review.<br><br>
									    We  have worked closely with the <a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJdvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKU">National Library  of Medicine (NLM)</a> to ensure the additional article information captured via  our unique publishing model (corresponding referee reports, author responses  and underlying data) is accessible in PMC. The inclusion of the referee reports  in PMC should help to provide referees with increased visibility and credit for  the time taken in providing referee reports.<br><br>
									    Find  out more in our <a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJd_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKV">blog post</a>.</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                                                     
                                    
									<!-- END Date and Intro --> 
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="220">
												<!-- BEGIN Prime -->
												<tr>
													<td style="background-color: #CB2D2D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJdPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKa">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_prime.jpg" alt="Prime - Logo"width="220" height="75"style="display:block;" title="Prime - Logo" border="0">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
                                                    
                                                    
														<strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJdfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKb" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - Link to HP">1,340 recommendations</a> added in the past month. Below is a selection:</strong>
												  </td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJCvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKY" title="Prime - Eval 1">Brain detox</a><br />
														Evidence  from a mouse study that sleep flushes out injurious metabolites from the adult  brain by enhancing the flow of interstitial fluid.<br>
Xie L, Kang H, Xu Q <em>et al</em>.
<br>
<em>Science</em>. 2013; 342:373-7</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJC_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKZ" title="Prime - Eval 2">What does pain look like?</a><br />
														Pain  is subjective, but<strong> </strong>a controversial  article suggests that an objective neural signature for pain may exist in brain  activation patterns viewed via fMRI.<br>
														Wager  TD, Atlas LY, Lindquist MA <em>et al</em>.<br>
														<em>N  Engl J Med</em>. 2013; 368:1388-97</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJCPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKe" title="Prime - Eval 3">No salt please</a><br />
														These  very simple experiments in plants show a new type of tropism -- halotropism --  whereby plant roots avoid salty environments.
                                                        <br>
                                                        Galvan-Ampudia  CS, Julkowska MM, Darwish E <em>et al</em>.<br>
                                                        <em>Curr Biol</em>. 2013; 23:2044-50</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:14px;">
														<strong style="font-weight:bold;">F1000Prime Reports</strong>
													</td>
												</tr>
												<tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                <tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJCfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKf" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - Reports: Link">Open-access review journal</a>, reporting on the hottest topics.</strong></td>
												</tr>
                                                
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												  <tr>
													<td width="220" height="103">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJDvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKc"><img src="http://f1000.com/prime/reports/m/6/04/feature-thumbnail.jpg" alt="F1000Prime Reports" width="220" style="display:block;" title="Prime - Reports: Thumbnail" border="0"/></a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJD_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKd" title="Prime - Reports: Article">Advances in treating psoriasis</a><br />
														New and better therapies for psoriasis and  psoriatic arthritis are headed for the clinic.<br />
														<em>F1000Prime Report</em> by Belge  K, Br&uuml;ck K, <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJDPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKi" title="Prime - Reports: FM">Ghoreschi K</a>.
													<br>
													<em>F1000Prime Rep</em> 2014, <strong>6</strong>:4<br><br>
                                                    <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJDfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKj" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;" title="Prime - All reports">See all recent <em>F1000Prime Reports</em>.</a></td>
											  	</tr>
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Prime -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Research -->
												<tr>
													<td style="background-color: #CB622D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJAvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKg">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_research.jpg" alt="Research - Logo" title="Research - Logo"width="220" height="75" style="display:block;" border="0">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<strong>Our innovative <a style="font-weight:bold; color:#CB622D; text-decoration: none;"href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJA_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKh">open access journal</a> offering rapid publication, open peer review and open data.<br>
                                                  <br>
                                                  Below is a selection of our latest peer reviewed articles:</strong></td>
										    </tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">OPINION ARTICLE</span><br />
												  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJAPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKm">Are we divorced from the species we study?</a> [v1; ref status: indexed, <a  style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJAfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKn">http://f1000r.es/2cr</a>]<br />
									          			Latest Published: 22 Nov 2013<br />
									          			Smith DR.<br>
									          			<em>F1000Research </em><strong>2</strong>:254</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><span style="font-family: arial, sans-serif; color: #999">SHORT RESEARCH ARTICLE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJBvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKk">Cladonia lichens on extensive green roofs: evapotranspiration, substrate temperature, and albedo</a> [v1; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJB_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKl">http://f1000r.es/2ha</a>]<br />
										      		    Published: 16 Dec 2013<br />
										      		    Heim A, Lundholm J.<br />
														<em>F1000Research</em> <strong>2:</strong>274</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999;">SHORT RESEARCH ARTICLE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJBPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKq">A novel role for syndecan-3 in angiogenesis</a> [v1; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJBfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKr">http://f1000r.es/2g6</a>]<br />
														Published: 09  Dec 2013<br />
														De  Rossi G, Whiteford JR.<br>
												        <em>F1000Research</em><strong> 2</strong>:270</td>
												</tr>
												
												
                                                
                                                
                                                
                                                <tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												
                                                <tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999;">RESEARCH ARTICLE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJGvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKo">A computational analysis of the long-term regulation of arterial pressure</a> [v2; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJG_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKp">http://f1000r.es/2hm</a>]<br />
														Latest Published: 06 Dec 2013<br />
														Beard DA, Pettersen KH, Carlson BE <em>et al</em>. 
										          <em>F1000Research</em><strong> 2</strong>:208</td>
												</tr>
                                                
                                                <tr>
													<td width="10" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
                                                <tr>
                                                <td align="center"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJGPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKu"><img src="http://webr.emv2.com/faculty1000/flying-man_eToC_img.gif" width="151" height="126"></a></td>
                                                </tr>
                                                <tr>
													<td width="10" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                <tr>
													<td width="30" colspan="3" style="background-color: #FFF"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJGfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKv" style="text-decoration:none; color:#CB622D;"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Submit-Now.gif" alt="Submit Now" width="136" height="27" border="0" style="display:block;" title="Submit your article" heigt="30"/>	</td>
												</tr>
                                                
                                                <tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
												<!-- END Research -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="1" colspan="7" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Trials -->
																								
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
<tr>
					  <td colspan="3" style="background-color: #2d8acb"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJHvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKs"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/header_trials.jpg" border="0" title="Trials - Logo" style="display:block;"width="220" height="75"></a></td>
							    </tr>
                                 <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
                                <tr>
                                  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style=" color:#2D8ACB; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJH_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKt" title="Trials - HP (Link)"><strong>A comprehensive listing</strong></a><strong> of clinical trial articles reviewed by the F1000  Faculty, with the most important tagged as recommended.</strong></td>
											  </tr>
                                
                                                <tr>
                                                  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
                                                
                                                
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Below is a taster of F1000Trials content. To read, please <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJHPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKy" style="font-weight:bold; color:#2D8ACB; text-decoration:none" title="Trials - Sign-in">sign-in</a> or <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJHfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKz" style="font-weight:bold; color:#2D8ACB; text-decoration:none" title="Trials - Register">register for free</a>:</td>
												</tr>
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              <tr>
                                                <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJEvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKw" title="Trials - Eval 1">Hope for HCV</a><br />
                                                  HCV-associated  end-stage liver disease will reach its peak over the next 10 years, but new  treatment options for difficult-to-treat patients are on the horizon.<br>
                                                  Lawitz  E, Poordad FF, Pang PS <em>et al</em>. <em>Lancet</em>. 2013;  S0140-6736(13)62121-2</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJE_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKx" title="Trials - Eval 2">What's in a name?</a><br />
												    An  RCT looks at the language used to describe palliative services for advanced  cancer patients and whether it affects their views.<br>
											      Maciasz  RM, Arnold RM, Chu E <em>et al</em>. <br>
											      <em>Support  Care Cancer</em>. 2013;  21:3411-9</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJEPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK2" title="Trials - Eval 3">Competing comorbidities</a><br>
												    This  work on whether comorbid anxiety disorders moderate the effects of bipolar disorder  psychotherapy &quot;shows the importance of treating comorbidities  adequately&quot;.<br>
												    Deckersbach  T, Peters AT, Sylvia L <em>et al</em>. 
                                                  <em>Am J Psychiatry</em>. 2013;  [Epub ahead of print]</td>
											  </tr>
                                              
                                              
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<!-- END Trials -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Posters -->
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="10"></td>
												</tr>
													<tr>
													<td colspan="3" style="background-color: #733380">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJEfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK3">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_posters.jpg" border="0" style="display:block;"width="220" height="75">														</a>													</td>
												</tr>
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<strong>	<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJFvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK0" style="text-decoration:none; color:#733380;" title="Poster - HP">Open Repository</a> for posters and slide presentations; completely free to view and submit.  Below is a selection:</strong>													</td>
											  </tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="30"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999; font-family:arial,sans-serif;">ECOLOGY</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJF_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK1"><img src="http://cdn.f1000.com/posters/thumbnails/257852455" border="0" width="80" heigt="89" title="Poster 1 (IMG)"alt="poster_1" style="display:block;"/></a> </td>
													<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td width="132" valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a  style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJFPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK6" title="Poster 1 (Link)">Calcareous sponges are fashion</a><br>
													Padua  A, Fonseca CA, Silva-Ferreira TCG <em>et al</em>.<br>
F1000Posters 2013,<br><strong>4</strong>:1377

                                                    </td>
												</tr>
												
                                                
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">COMPUTATIONAL BIOLOGY</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJFfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK7"><img src="http://cdn.f1000.com/posters/thumbnails/258295306" alt="Poster 2" width="80" height="113" style="display:block;" title="Poster 2 (IMG)" border="0" heigt="113"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJKvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK4" title="Poster 2 (Link)">Biomedical text mining for disease-gene discovery</a><br>
                                                    ElShal  S, Davis J, Moreau Y.<br>
F1000Posters 2013,<br><strong>4</strong>:1516</td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><span style="color:#383838;font-family:arial,sans-serif;font-size:12px;"></span></td>
												</tr>
                                                
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												 <tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">ANESTHESIOLOGY & PAIN MANAGEMENT</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJK_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK5"><img src="http://cdn.f1000.com/posters/thumbnails/257660741" alt="Poster 2" width="80" height="80" style="display:block;" title="Poster 3 (IMG)" border="0" heigt="114"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJKPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK-" title="Poster 3 (Link)">Pharmacokinetic modeling for optimization of opioid dosing regimens</a><br>
													Linares  O, Daly D, Stefanovski D <em>et al</em>.<br>
F1000Posters 2013,<br><strong>4</strong>:1298</td>
												</tr>
												
                                                <tr>
													<td height="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" heigt="20">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJKfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK_">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Deposit-Now.gif" border="0" width="136" heigt="27" title="Deposit Now" alt="Deposit a Poster" style="display:block;"/>														</a>													</td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Posters -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>	
								</table>
							</td>
							<!-- END Left Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Right Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="159">
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" heigt="22">
											<!-- BEGIN Share Widget -->
											<a href="http://p4trc.emv2.com/HSL?lang=us&a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLJ3zyvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlCt"><img src="http://p4trc.emv2.com/dispatcher/images/share/swmn01a.gif" border="0" align="absmiddle" title="Share this email"></a>
											<!-- END Share Widget -->
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<!-- BEGIN News Section -->
									
                                
                                    
                                    

                                    <tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="font-weight:bold;color:#018181;font-family:arial,sans-serif;font-size:14px;">F1000 Specialist programme</td>
								  	  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="color:#383838;font-family:arial,sans-serif;font-size:11px;">If  you would like to get better connected with Faculty of 1000, please join our  network of F1000 Specialists. More details <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJLvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK8" style="font-weight:bold; color:#018181;font-family:arial,sans-serif;font-size:12px;text-decoration:none;">here</a>.<br>
										  <br>
                                        <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJL_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK9"><img src="http://webr.emv2.com/faculty1000/Apply-Now.gif" border="0"></a>
                                        
                                      </td>
									  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
                                    
									
									
									<tr>
										<td colspan="4" heigt="600">
										    <!-- begin ad tag 160x600  ad slot size -->
											 <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJLPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLC"><img src="http://p4trr.emv2.com/IL/9/2/1/1101019921/1032294236.jpg" style="display:block;"width="160" height="600" border="0" alt="" title="Skyscraper"/></a>
											<!-- End ad tag 160x600  ad slot size -->
										</td>
									</tr>
									<tr>
										<td colspan="4" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
									</tr>
                                    
                                    
                                     <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
				          <!-- END News Section -->
									
									 <tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="font-weight:bold;color:#383838;font-family:arial,sans-serif;font-size:14px;"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJLfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLD"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/F1000tips.gif" alt="F1000Tips" border="0" style="display:block;" width="139" height="139"></a></td>
								  	  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="color:#383838;font-family:arial,sans-serif;font-size:11px;">Follow <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJIvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLA" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">@F1000Tips</a> on  Twitter for tips, tricks, and customer support for all Faculty of 1000 services.<br></td>
									  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
                                    
				          <!-- END of twitter section -->
                                    
								
                                    
								</table>
                                
                                
                                
							</td>
							<!-- END Right Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
						</tr>
						<!-- END Content -->
						<!-- BEGIN Footer -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJI_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLB"><img src="http://p4trr.emv2.com/IL/9/2/1/1101019921/539686700.jpg" style="display:block;"width="468" height="60" border="0" alt="" title="Bottom Banner"/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Footer -->
						<!-- BEGIN Footer -->
						<tr>
							<td colspan="5">
								<table border="0" cellpadding="0" cellspacing="10" style="background: #222222; border:1px solid #ccc;" width="100%">
									<tr>
										<td style="color:#CCCCCC;font-family:arial,sans-serif;font-size:11px;">
											In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).<br><br>
											<span class="hide-forwarded">You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may <a href="http://p4trc.emv2.com/HP?a=ENX7CqkWrP9-8SA9MKJqeHLnGHxKLjKJIPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLG" style="color:#CCCCCC;text-decoration:none;" target="_blank"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>unsubscribe</b></font></a> at any time. </span>For further information or enquiries please contact Customer Services at <a href="mailto:info@f1000.com" style="color:#CCCCCC;text-decoration:none;"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>info@f1000.com</b></font></a>.<br /><br />
											Faculty of 1000 Ltd &#124; Science Navigation Group<br>
											<b>Registered in England and Wales with Company Number 3739756</b><br>
											Middlesex House, 34-42 Cleveland Street &#124; London, W1T 4LB &#124; United Kingdom
										</td>
									</tr>
								</table>
							</td>
						</tr>
						<!-- END Footer -->
					</table>
				</td>
			</tr>
		</table>
	<img src="http://p4trc.emv2.com/HO?DdX7CqkWrP9-8SA9MOPv4OvnGHxKLLhQQgjtS5kGWZDbKrA.gif" border="0" alt="" width="1" height="1" /></body>
</html>
--2466696807521937--

